TOKYO (AP) — A remote-controlled robot has safely returned with a tiny piece of melted fuel it collected from inside one of three damaged reactors at the tsunami-hit Fukushima Daiichi nuclear power plant for the first time since the 2011 meltdown.
The Tokyo Electric Power Company Holdings, which manages the plant, said Saturday that the extendable fishing rod-like robot successfully clipped a piece of gravel of about 5 millimeters (0.2 inches), the size of a tiny bit of granola, from the top surface of a mound of molten fuel debris that sits on the bottom of the No. 2 reactor’s primary containment vessel.
The “telesco” robot, with its frontal tongs still holding the melted fuel bit, returned to the enclosed container for safe storage after workers in full hazmat gear pulled it out of the containment vessel earlier Saturday.
The sample return marks the first time the melted fuel is retrieved out of the containment vessel. But the mission is not over until it's certain that the sample's radioactivity is below a set standard and safely placed into a container.
If the radioactivity exceeds the limit, the robot must go back inside the reactor to find another piece. TEPCO officials said they expect the piece is small enough to meet the requirement.
The mission initially started in August for what was supposed to be a two-week round trip but had been suspended twice due to mishaps.
First one was the procedural mistake at the beginning that held up the work for nearly three weeks, then the robot’s two cameras designed to transmit views of the target areas for its operators in the remote control room failed. The camera problem required the robot to be pulled out all the way for replacement before the mission resumed Monday.
Fukushima Daiichi lost its key cooling systems during the 2011 earthquake and tsunami, causing meltdowns in its three reactors. An estimated 880 tons of fatally radioactive molten fuel remains in them, and TEPCO has carried out a number of robotic probes to figure out how to decommission the plant.
Telesco on Wednesday successfully clipped a piece presumably measuring less than 3 grams (0.1 ounce) from the planned area right underneath the Unit 2 reactor core, from which large amounts of melted fuel fell during the meltdown 13 years ago, TEPCO said.
Plant chief Akira Ono said only the tiny spec can provide key data to plan decommissioning strategy, develop necessary technology and robots and retroactively learn how the accident had developed.
The government and TEPCO have set a 30-to-40-year target for the cleanup, which experts say is overly optimistic and should be updated.
No specific plans for the full removal of the fuel debris or its final disposal have been decided.
FILE - Tokyo Electric Power Company Holdings, also known as TEPCO, the operator of Japan's wrecked Fukushima Daiichi nuclear power plant, reveals a robot to be used to retrieve debris at the power plant in Kobe, western Japan, May 28, 2024. (Kyodo News via AP, File)
A device to remove debris from a reactor at the damaged Fukushima Nuclear power plant demonstrates to pinch a stone, as revealed in Kobe, western Japan, May 28, 2024. (Kyodo News via AP, File)
SAN FRANCISCO & JACKSONVILLE, Fla.--(BUSINESS WIRE)--Jan 12, 2026--
Abridge, the leading enterprise-grade AI for clinical conversations, is collaborating with Availity, the nation’s largest real-time health information network, to launch a first-of-its kind prior authorization experience. The engagement uses cutting-edge technology grounded in the clinician-patient conversation to facilitate a more efficient process between clinicians and health plans in medical necessity review.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260112960386/en/
Rather than creating parallel AI systems across healthcare stakeholders, Abridge and Availity are working together to ensure shared clinical context at the point of conversation powers administrative processes, such as prior authorization review and submission, improving outcomes for patients and the teams delivering care.
This collaboration unites two trusted and scaled organizations: combining Abridge’s enterprise-grade AI platform, serving over 200 health systems and projected to support over 80 million patient-clinician conversations in 2026, with Availity’s next-generation, FHIR-native Intelligent Utilization Management solution, which helps payers and providers digitize and operationalize coverage requirements within administrative workflows.
Availity’s FHIR-native APIs enable fast, scalable, and secure connectivity of payer information across the entire healthcare ecosystem. With Abridge’s Contextual Reasoning Engine technology, clinicians can gain visibility into relevant clinical information during the conversation to support documentation aligned with prior authorization requirements.
“At Availity, we’ve invested in building AI-powered, FHIR-native APIs designed to bring clinical policy logic directly into provider workflows,” said Russ Thomas, CEO of Availity. “By embedding our technology at the point of conversation, we’re enabling faster, more transparent utilization management decisions rooted in clinical context. We’re excited to collaborate with Abridge and to demonstrate what’s possible when payer intelligence meets real-time provider workflows.”
The development of real-time prior authorization is just a component of a broader revenue cycle collaboration that is focused on applying real-time conversational intelligence across the patient, provider, and payer experiences. The companies intend to support integration by collaborating on workflow alignment between their respective platforms in the following areas:
“Abridge and Availity are each bringing national scale, deep trust, and a track record of solving important challenges across the care and claims experience to this partnership,” said Dr. Shiv Rao, CEO and Co-Founder of Abridge. “We’re building real-time bridges between patients, providers, and payers, unlocking shared understanding, focused at the point of conversation.”
About Availity
Availity empowers payers and providers to deliver transformative patient experiences by enabling the seamless exchange of clinical, administrative, and financial information. As the nation's largest real-time health information network, Availity develops intelligent, automated, and interoperable solutions that foster collaboration and shared value across the healthcare ecosystem. With connections to over 95% of payers, more than 3 million providers, and over 2,000 trading partners, Availity provides mission-critical connectivity to drive the future of healthcare innovation. For more information, including an online demonstration, please visit www.availity.com or call 1.800.AVAILITY (282.4548). Follow us on LinkedIn.
About Abridge
Abridge was founded in 2018 to power deeper understanding in healthcare. Abridge is now trusted by more than 200 of the largest and most complex health systems in the U.S. The enterprise-grade AI platform transforms medical conversations into clinically useful and billable documentation at the point of care, reducing administrative burden and clinician burnout while improving patient experience. With deep EHR integration, support for 28+ languages, and 50+ specialties, Abridge is used across a wide range of care settings, including outpatient, emergency department, and inpatient.
Abridge’s enterprise-grade AI platform is purpose-built for healthcare. Supported by Linked Evidence, Abridge is the only solution that maps AI-generated summaries to source data, helping clinicians quickly trust and verify the output. As a pioneer in generative AI for healthcare, Abridge is setting the industry standard for the responsible deployment of AI across health systems.
Abridge was awarded Best in KLAS 2025 for Ambient AI in addition to other accolades, including Forbes 2025 AI 50 List, TIME Best Inventions of 2024, and Fortune’s 2024 AI 50 Innovators.
Abridge and Availity Collaborate to Redefine Payer-Provider Synergy at the Point of Conversation
Abridge and Availity Collaborate to Redefine Payer-Provider Synergy at the Point of Conversation
